SUSAN HILSENBECK to Breast Neoplasms, Male
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Breast Neoplasms, Male.
Connection Strength
0.036
-
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011 Oct; 129(3):819-27.
Score: 0.023
-
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002 Jun 01; 20(11):2701-12.
Score: 0.012